RMCM
EW icon

Reynders McVeigh Capital Management’s Edwards Lifesciences EW Stock Holding History

Reynders McVeigh Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,582
Closed -$423K – 206
2024
Q2 		$423K Hold
4,582
– – 0.02% 146
2024
Q1 		$438K Sell
4,582
-870
-16% -$73.1K 0.03% 144
2023
Q4 		$416K Buy
5,452
+625
+13% +$43.5K 0.03% 143
2023
Q3 		$334K Sell
4,827
-374
-7% -$30.1K 0.02% 158
2023
Q2 		$491K Sell
5,201
-165
-3% -$14.3K 0.03% 138
2023
Q1 		$444K Buy
5,366
+275
+5% +$21.6K 0.03% 143
2022
Q4 		$380K Sell
5,091
-77
-1% -$5.93K 0.03% 160
2022
Q3 		$427K Buy
5,168
+1,055
+26% +$102K 0.03% 150
2022
Q2 		$391K Hold
4,113
– – 0.03% 165
2022
Q1 		$484K Hold
4,113
– – 0.03% 158
2021
Q4 		$533K Sell
4,113
-1
-0% -$117 0.03% 159
2021
Q3 		$466K Hold
4,114
– – 0.03% 159
2021
Q2 		$426K Sell
4,114
-87
-2% -$8.2K 0.03% 168
2021
Q1 		$351K Buy
4,201
+3
+0.1% +$254 0.02% 183
2020
Q4 		$383K Buy
4,198
+4
+0.1% +$332 0.03% 170
2020
Q3 		$335K Sell
4,194
-84
-2% -$6.55K 0.03% 173
2020
Q2 		$296K Buy
4,278
+183
+4% +$13K 0.03% 177
2020
Q1 		$257K Buy
4,095
+24
+0.6% +$1.73K 0.03% 166
2019
Q4 		$317K Buy
+4,071
New +$318K 0.03% 188

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Reynders McVeigh Capital Management's EW Position: Q3 2024 in Review

Reynders McVeigh Capital Management sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 4,582 shares — an estimated $423K sold.

Reynders McVeigh Capital Management first reported a position in EW in Q4 2019 and held it in 19 quarters. The position peaked at $533K in Q4 2021. 1,195 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Reynders McVeigh Capital Management reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • Reynders McVeigh Capital Management sold 4,582 Edwards Lifesciences shares in Q3 2024, an estimated $423K.
  • Reynders McVeigh Capital Management first reported a position in Edwards Lifesciences in Q4 2019 and held it in 19 quarters.
  • Reynders McVeigh Capital Management's Edwards Lifesciences position peaked at $533K in Q4 2021.
  • 1,195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.